CML with e6a2 BCR-ABL1 transcript: an aggressive entity?

Ann Hematol. 2011 Oct;90(10):1241-3. doi: 10.1007/s00277-011-1169-4. Epub 2011 Feb 8.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Disease Progression
  • Fatal Outcome
  • Fusion Proteins, bcr-abl / chemistry
  • Fusion Proteins, bcr-abl / genetics
  • Fusion Proteins, bcr-abl / metabolism*
  • Gene Rearrangement
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / metabolism
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy
  • Male
  • Middle Aged
  • Multiple Organ Failure
  • Postoperative Complications / physiopathology
  • Sepsis / physiopathology
  • Stem Cell Transplantation

Substances

  • Fusion Proteins, bcr-abl